A. Bright

Journal Pre-proof Phase II feasibility study of the efficacy, tolerability and impact on the gut microbiome of a low residue (fibre) diet in adult patients with mitochondrial disease.

M. Jackson, D. Turnbull, C. Lamb, 2022 .

Phase II Feasibility Study of the Efficacy, Tolerability, and Impact on the Gut Microbiome of a Low-Residue (Fiber) Diet in Adult Patients With Mitochondrial Disease

M. Jackson, D. Turnbull, C. Lamb, 2022, Gastro Hep Advances.

mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease

Robert W. Taylor, D. Turnbull, R. McNally, 2018, EMBO molecular medicine.

Height as a Clinical Biomarker of Disease Burden in Adult Mitochondrial Disease

Robert W. Taylor, D. Turnbull, A. Schaefer, 2017, The Journal of clinical endocrinology and metabolism.

Pseudo‐obstruction, stroke, and mitochondrial dysfunction: A lethal combination

Robert W. Taylor, D. Turnbull, Y. Yiannakou, 2016, Annals of neurology.

A case‐comparison study of pregnant women with mitochondrial disease – what to expect?

H. Devine, R. Mcfarland, A. Blain, 2019, BJOG : an international journal of obstetrics and gynaecology.

Cognitive deficits in adult m.3243A>G‐ and m.8344A>G‐related mitochondrial disease: importance of correcting for baseline intellectual ability

Robert W. Taylor, D. Turnbull, A. Schaefer, 2019, Annals of clinical and translational neurology.

Height as a Clinical Biomarker of Disease Burden in Adult Mitochondrial Disease

D. Turnbull, A. Schaefer, T. Cheetham, 2018, The Journal of clinical endocrinology and metabolism.